Page 18 - E Ltd News Today

Pfizer and the Indian health ministry did not immediately respond to Reuters request for comments. The drugmaker has not yet sought permission for use of its vaccine in India. The country, which rolled out one of the worlds largest vaccination drives earlier this year, has been relying heavily on the AstraZeneca vaccine produced by the Serum Institute of India and a home-grown shot produced by Bharat Biotech.

Indian health authorities are also in an advanced stage of negotiations with Johnson & Johnson, which has a deal with India-based Biological E. Ltd, to manufacture as many as 600 million doses, starting as soon as this month, the Journal reported.

(Reuters) -India is in talks to buy 50 million doses of Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine, the Wall Street Journal reported https://www.wsj.com/articles/india-looks-to-western-covid-19-vaccines-to-ease-supply-shortage-11628674884?mod=latest_headlines on Wednesday, citing people familiar with the matter.

Authorities are also in an advanced stage of negotiations with Johnson & Johnson

The drugmaker has not yet sought permission for use of its vaccine in India.

India approves J&J vaccine; no delivery timeline yet

The European Medicines Agency said its safety committee had studied cases of menstrual disorders reported after vaccination, adding it had requested more data from vaccine developers to assess the issue. Australia suffers worst COVID day this year with millions in lockdown Australia saw a record daily number of new coronavirus cases this year on Saturday, with the country's most populous states of New South Wales, Victoria and Queensland recording a total of 361 cases of the highly infecti...

The pharmaceutical giant had applied for emergency use approval of its vaccine, the company had said on Friday. The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J had said.

Professor Neil Ferguson has admitted that his prediction that Britain would face 100,000 Covid cases per day once lockdown restrictions eased on July 19 was wrong.

India has approved Johnson & Johnson's single-dose COVID-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet.The pharmaceutical giant had applied for emergency use approval of its vaccine, the company had said on Friday.The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological...